Haiping Dai, Depei Wu, Suning Chen, Yu Wang. "Phase 1/2, multi-center, open-label clinical study to evaluate the safety, pharmacokinetics, and efficacy of Zefamenib combined with chemotherapy or targeted Agents in patients with Acute Myeloid Leukemia." Blood, 2025. doi:10.1182/blood-2025-8257